Loading news...
ACEL, CROX, ALTO and DLB gain appeal as easing inflation boosts rate-cut hopes and earnings estimates climb for these consumer discretionary picks.
As of March 9, 2026, three stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Strong improvement in fiscal performance has sent Alto Ingredients up 180% over the past year. Continued capacity expansion is well-cited as a possible catalyst for shares, but another catalyst remains in motion for this industrial alcohol and renewable energy company. That would be Alto's potential to get acquired by a smaller competitor.
Kid Brands (OTCMKTS:KIDBQ - Get Free Report) and Alto Ingredients (NASDAQ: ALTO - Get Free Report) are both consumer discretionary companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, dividends, analyst recommendations and risk. Earnings and Valuation This table compares Kid
Reynolds Consumer Products (NASDAQ: REYN - Get Free Report) and Alto Ingredients (NASDAQ: ALTO - Get Free Report) are both consumer discretionary companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, analyst recommendations and earnings. Analyst Ratings This is a breakdown
Alto Ingredients Inc (NASDAQ: ALTO) shares are trading higher again Friday, extending a powerful two-day rally after the ethanol and specialty alcohol producer's blowout earnings report late Wednesday sparked a roughly 50% surge on Thursday. Here's what investors need to know.
ALTO, SHG and ESCA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 6, 2026.
Alto Ingredients reported strong fourth-quarter results with profitability well ahead of consensus expectations. Management attributed the outperformance to a combination of improved crush margins, high-margin export sales, lower operating expenses, and the recognition of clean fuel production tax credits. While Q1 will be impacted by seasonality and weather-related downtime, 2026 as a whole should benefit from strong export volumes and a doubling of tax credits.
Alto Ingredients Inc (NASDAQ: ALTO) shares are surging Thursday afternoon as investors cheer a strong earnings report reinforcing the renewable fuels producer's turnaround. Here's what investors need to know.
Alto Ingredients, Inc. (ALTO) Q4 2025 Earnings Call Transcript
- Results Improved in All Segments - - Q4 2025 Gross Profit of $15.2 Million Increased $16.6 Million, Q4 2025 Net Income of $21.5 Million, or $0.28 per Share, Improved $63.5 Million, and Q4 2025 Adjusted EBITDA of $27.9 Million Grew $35.6 Million Compared to Q4 2024 - PEKIN, Ill., March 04, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, reported its financial results for the quarter and year ended December 31, 2025.
Ceconomy (OTCMKTS:MTTRY - Get Free Report) and Alto Ingredients (NASDAQ: ALTO - Get Free Report) are both consumer discretionary companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation. Valuation and Earnings This table compares Ceconomy and
PEKIN, Ill., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO) a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced it will release its fourth quarter and year-end 2025 financial results after the close of market on Wednesday, March 4, 2026.
Alto Ingredients (NASDAQ: ALTO - Get Free Report) is expected to be announcing its Q4 2025 results before the market opens on Wednesday, March 4th. Analysts expect Alto Ingredients to post earnings of $0.02 per share and revenue of $234.83 million for the quarter. Parties may visit the the company's upcoming Q4 2025 earning results page
Alto Ingredients, Inc. (NASDAQ: ALTO - Get Free Report) dropped 5.2% during trading on Tuesday. The stock traded as low as $2.52 and last traded at $2.54. Approximately 556,388 shares changed hands during trading, a decline of 33% from the average daily volume of 824,512 shares. The stock had previously closed at $2.68. Wall Street
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $anro #cns--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the completion of patient enrollment in its Phase 2 proof-of-concept clinical trial evaluating ALTO-101, a novel, transdermal phosphodiesterase-4 (PDE4) inhibitor, for the treatment of cognitive impairment associated with schizophrenia (CIAS). Topline data from the.
Alto Ingredients (ALTO) has transitioned from a pure ethanol producer to a diversified, higher-margin specialty ingredients and CO₂ business. Q3 results confirm a structural earnings inflection, with GAAP profitability, improved product mix, and cost discipline driving sustainable margin expansion. Section 45Z tax credits, effective 2026, will materially reset ALTO's earnings floor, providing multi-year regulatory cash flow visibility.
ALTO's Western production unit fuels earnings strength with premium pricing, LCFS tailwinds, and margin resilience.
ALTO's Pekin segment fuels earnings with high-margin alcohols, diversifying revenues and boosting long-term growth potential.
ALTO and GPRE both target low-carbon growth, but ALTO's diversification and lower valuation give it an edge.